«Tit» «Name» «Fam_Nam» «Organization» «Address1» «Address_2» «PO_Box» «City». «Country» Sevilla, February, 2016
|
|
- Joseph Nicholson
- 5 years ago
- Views:
Transcription
1 «Tit» «Name» «Fam_Nam» «Organization» «Address» «Address_» «PO_Box» «City». «Country» Proficiency Test 5- Laboratory Code: «Lab_code» Sevilla, February, 6 Dear participants, Enclosed you will find the report of the Proficiency Test 5- on Drugs of Abuse in Hair, organized by the Society of Hair Testing. Each of the participating laboratories received an identifying code. Your particular code is «Lab_code». Sets of three samples were sent to forty four participating laboratories. Forty one of them sent the report forms back. Sample contents were as follows: Sample A contained opiates (6-MAM, morphine, codeine, acetylcodeine and heroin), cocainics (cocaine, BE, norcocaine and traces of cocaethylene) and cannabis (THC, CBD, CBN and THC-COOH). It also contained methadone, dihydrocodeine, diazepam, nordiazepam, tramadol, EME and AEME. Sample B contained contained traces of cocainics (cocaine, BE). Median concentration of cocaine is below the cut-off proposed by SoHT. Sample C opiates (6-MAM, morphine, codeine, acetylcodeine and heroin), cocainics (cocaine, BE, cocaethylene and norcocaine) traces of amphetamine compounds (amphetamine methamphetamine and MDMA) and cannabis (THC, CBD, CBN and THC-COOH). It also contained dihydrocodeine, diazepam, nordiazepam, tramadol, EME, AEME and traces of methadone.
2 has been calculated based on robust estimators (median instead of mean and interquartile instead of standard deviation). has been calculated as follows: = (x - χ) / IQR Where: x: Concentration reported by the participant χ: Median concentration obtained from the participating laboratories IQR: Interquartile range: It is calculated as: Q-Q (the upper quartile minus the lower quartile) Q: Third quartile (percentile 75) Q: First quartile (percentile 5) Decision criteria The following criteria have been adopted: Satisfactory results: ± Questionable results: < Unsatisfactory results: Yours faithfully, Carmen Jurado
3 Laboratory Code: Lab QUALITATIVE RESULTS Sample A Sample B Sample C Substances A T F Substances A T F Substances A T F MAM P D N MAM P Morphine P Morphine P Codeine P Codeine P Cocaine P Cocaine P BE P BE P THC P Amphetamine* P THC-COOH P Methamphetamine* P MDMA* THC P P THC-COOH * The median concentrations of amphetamine, methamphetamine and MDMA in Sample C are.6 ng/mg,. ng/mg and. ng/mg, respectively. All of them are lower than the cut-off proposed by SoHT (. ng/mg). P A: Your answer T: True answer F: False answer P: Positive N: Negative NR: Not reported NA: Not analyzed FN: False Negative FP: False Positive Comments: Sample A contains methadone, CBD, CBN, norcocaine, dihydrocodeine, diazepam, tramadol and traces of cocaethylene (. ng/mg, median concentration). Sample B contains traces of cocaine (.6 ng/mg, median concentration) and benzoylecgonine (.7 ng/mg, median concentration). Sample C contains CBD, CBN, norcocaine, cocaethylene, dihydrocodeine, diazepam and tramadol and traces of methadone
4 MAM conc. (ng/mg) MAM- Sample A Lab. MAM (ng/mg) Result Lab. MAM (ng/mg) Result 9,75 -,5 Questionable,,5 Satisfactory,9 -, Questionable,7, Satisfactory 5, -,9 Satisfactory 5,,7 Satisfactory Average,5 Satisfactory Satisfactory 9 6,6 -,5 6 5,5,7 SD, 6, -, Satisfactory 5,76,5 Satisfactory CV% 5, 5 7, -, Satisfactory 6,,5 Satisfactory Median,9 6 7, -, Satisfactory 5 6,,66 Satisfactory Minimum,75 9, -, Satisfactory 6,5,69 Satisfactory Quartile 5,7 6 9, -,7 Satisfactory 7 6,7,76 Satisfactory Quartile 75,95 9,9 -,67 Satisfactory 7,77,9 Satisfactory Maximum 9,7 7,5 -,55 Satisfactory 6,9,7 Satisfactory Iqr,6 5,7 -,5 Satisfactory 9,7, Satisfactory, -, Satisfactory >,5 -, Satisfactory > 5 5, -,9 Satisfactory P, -, Satisfactory,56 -, Satisfactory,97 -, Satisfactory,9 -, Satisfactory 7,, Satisfactory 6,6, Satisfactory,95,6 Satisfactory,,7 Satisfactory,,7 Satisfactory,, Satisfactory,, Satisfactory
5 5 Morphine- Sample A Morphine conc. (ng/mg) Lab. Morphine (ng/mg Result Lab. Morphine (ng/mg) Result,9 -,6 Satisfactory 7,,6 Satisfactory,9 -, Satisfactory,,96 Satisfactory 5, -,9 Satisfactory,5,5 Satisfactory Average,95 9,5 -,9 Satisfactory,79,67 Satisfactory SD, 5,6 -, Satisfactory,9,7 Satisfactory CV% 57, 6,6 -, Satisfactory 6,9,7 Satisfactory Median,7,7 -,79 Satisfactory 7 5,,79 Satisfactory Minimum,9 6, -,7 Satisfactory 9 5,6, Satisfactory Quartile 5,7,57 -, Satisfactory 5,5,9 Satisfactory Quartile 75,,6 -, Satisfactory 5 5,7, Satisfactory Maximum,,7 -, Satisfactory 6,5, Satisfactory Iqr,, -,7 Satisfactory 5 6,6,5 Satisfactory, -,7 Satisfactory 7,, Questionable 6,5 -, Satisfactory,,7 Unsatisfactory,9 -, Satisfactory P 7, -, Satisfactory 9, -, Satisfactory, -, Satisfactory,6 -, Satisfactory,7 Satisfactory,, Satisfactory,7,5 Satisfactory,5,6 Satisfactory,5, Satisfactory 5,59, Satisfactory 6,, Satisfactory
6 ,5 Codeine- Sample A Codeine conc. (ng/mg),5, Lab. Codeine (ng/mg Result Lab. Codeine (ng/mg) Result,6 -, Satisfactory,9, Satisfactory 5, -, Satisfactory 6,,9 Satisfactory, -, Satisfactory 7,5,6 Satisfactory Average, 9, -,7 Satisfactory 7,5,6 Satisfactory SD,5 6, -,9 Satisfactory,9,7 Satisfactory CV%,75 6, -,9 Satisfactory 6,,79 Satisfactory Median,79,9 -,7 Satisfactory,,79 Satisfactory Minimum,6 5,9 -,7 Satisfactory 9,, Satisfactory Quartile 5,6,5 -,6 Satisfactory 5,,9 Satisfactory Quartile 75, 9,6 -, Satisfactory,,7 Satisfactory Maximum,6 -, Satisfactory 5,,7 Satisfactory Iqr,,6 -,5 Satisfactory,, Questionable,65 -, Satisfactory,67 -, Satisfactory,6 -,6 Satisfactory,7 -, Satisfactory 7,7 -, Satisfactory,75 -, Satisfactory,7 -, Satisfactory 6,, Satisfactory,, Satisfactory 5,,7 Satisfactory,,7 Satisfactory,,7 Satisfactory,7,9 Satisfactory,9, Satisfactory
7 Cocaine conc. (ng/mg) 6 Cocaine- Sample A Lab. Cocaine (ng/mg Result Lab. Cocaine (ng/mg) Result,6 -, Questionable 7,5, Satisfactory,9 -,7 Satisfactory 6 7,5, Satisfactory 5, -,7 Satisfactory 7,6,5 Satisfactory Average 6, 9, -,6 Satisfactory 5 7,69,55 Satisfactory SD, 6, -,5 Satisfactory 7,7,56 Satisfactory CV%,6 5,6 -,6 Satisfactory 7,5,69 Satisfactory Median 6,,9 -,95 Satisfactory,, Satisfactory Minimum,6, -,7 Satisfactory 6,5,9 Satisfactory Quartile 5 5,, -,59 Satisfactory,75,97 Satisfactory Quartile 75 7,65 5,9 -,56 Satisfactory,,99 Satisfactory Maximum, 6 5,6 -,7 Satisfactory 9,77, Satisfactory Iqr,5 9 5, -,5 Satisfactory,,7 Satisfactory 9 5,5 -, Satisfactory,,55 Satisfactory 5,6 -,6 Satisfactory P 5 5,9 -, Satisfactory 6, -, Satisfactory 6 6, -, Satisfactory 6, -, Satisfactory 7 6, -, Satisfactory 6, Satisfactory 6,5,9 Satisfactory 6,7,6 Satisfactory 7,, Satisfactory 7,,6 Satisfactory 7 7,,6 Satisfactory 7,, Satisfactory
8 BE conc. (ng/mg) 6 6 BE- Sample A Lab. BE (ng/mg) Result Lab. BE (ng/mg) Result, -,7 Satisfactory,,5 Satisfactory 7,7 -,7 Satisfactory,,5 Satisfactory 5,5 -, Satisfactory,5,6 Satisfactory Average 7,9, -,7 Satisfactory,66,67 Satisfactory SD, 9, -, Satisfactory,9,7 Satisfactory CV%,5 5,6 -, Satisfactory,5,77 Satisfactory Median, 5, -,75 Satisfactory 7,, Satisfactory Minimum, 6 5, -,75 Satisfactory,9,99 Satisfactory Quartile 5 6, 6 5,67 -,6 Satisfactory,, Satisfactory Quartile 75, 6, -,5 Satisfactory 6,, Satisfactory Maximum 6, 6,6 -, Satisfactory 6,, Questionable Iqr,9 5 6,9 -,9 Satisfactory >5 6,9 -, Satisfactory P 6,95 -, Satisfactory 5 7, -,6 Satisfactory 9 7, -,5 Satisfactory 7, -, Satisfactory 7, -,9 Satisfactory 9, Satisfactory,,5 Satisfactory 6,,7 Satisfactory,, Satisfactory,7, Satisfactory 7,9, Satisfactory,95, Satisfactory 6 9,,7 Satisfactory
9 ,9 THC- Sample A 9, 6 THC conc. (ng/mg),7,6,5,,,, Lab. THC Result 5, -, Satisfactory, -,7 Satisfactory 9, -,6 Satisfactory Average, 7, -,6 Satisfactory SD, 6, -,56 Satisfactory CV% 9,7, -,5 Satisfactory Median,6 7, -, Satisfactory Minimum,,7 -,6 Satisfactory Quartile 5,,5 -, Satisfactory Quartile 75,,6 Satisfactory Maximum,9,69, Satisfactory Iqr,5,7, Satisfactory 5,7, Satisfactory,, Satisfactory 5,9,6 Satisfactory 5,, Satisfactory,, Satisfactory 9,9 7, Unsatisfactory P 6 P
10 6 MAM conc. (ng/mg) 5 MAM- Sample C Lab. MAM (ng/mg) Result Lab. MAM (ng/mg) Result 5, -, Satisfactory,7,9 Satisfactory,5 -,9 Satisfactory,,6 Satisfactory 9, -, Satisfactory 7,,6 Satisfactory Average,75 9,6 -,9 Satisfactory,9, Satisfactory SD, 9,6 -,9 Satisfactory,9, Satisfactory CV%, 6, -, Satisfactory 6,9,6 Satisfactory Median,5 5,5 -, Satisfactory 5,97,9 Satisfactory Minimum, 5, -,7 Satisfactory,99, Satisfactory Quartile 5,56 6,5 -,7 Satisfactory,5,5 Satisfactory Quartile 75,9,5 -,6 Satisfactory,69,9 Satisfactory Maximum 5,5,57 -,66 Satisfactory,9,9 Satisfactory Iqr,,5 -,65 Satisfactory 5,,6 Satisfactory,6 -,6 Satisfactory 5,,6 Satisfactory,7 -,5 Satisfactory 6 5,5,56 Satisfactory 5,9 -, Satisfactory P,9 -, Satisfactory, -,6 Satisfactory,6 -, Satisfactory, -,9 Satisfactory, -, Satisfactory 7,, Satisfactory,5, Satisfactory,5, Satisfactory 7,5,6 Satisfactory,57,9 Satisfactory 6,6, Satisfactory
11 ,5 Morphine- Sample C 5 5 Morphine conc. (ng/mg),5, Lab. Morphine (ng/mg) Result Lab. Morphine (ng/mg) Result, -,6 Satisfactory 6,, Satisfactory 5, -, Satisfactory 7,, Satisfactory 6, -, Satisfactory 9,, Satisfactory Average,95, -, Satisfactory 7,5, Satisfactory SD,5 9, -,6 Satisfactory,7,5 Satisfactory CV% 5,6,6 -,99 Satisfactory,,75 Satisfactory Median, 6,5 -,9 Satisfactory 5,9,96 Satisfactory Minimum,,5 -,9 Satisfactory,,99 Satisfactory Quartile 5,6,5 -, Satisfactory 6,7,5 Satisfactory Quartile 75,55 5,5 -, Satisfactory,5, Satisfactory Maximum,7,66 -,5 Satisfactory,9, Satisfactory Iqr,5 9,67 -,9 Satisfactory,67,6 Satisfactory,7 -, Satisfactory 5,5, Unsatisfactory,7 -, Satisfactory,7, Unsatisfactory,75 -, Satisfactory P,77 -,6 Satisfactory 5,7 -, Satisfactory, -, Satisfactory, Satisfactory 7, Satisfactory,9, Satisfactory 6,9,7 Satisfactory,9,9 Satisfactory,9, Satisfactory,99,6 Satisfactory,, Satisfactory
12 ,6,5 Codeine- Sample C 5 Codeine conc. (ng/mg),,,, Lab. Codeine (ng/mg) Result Lab. Codeine (ng/mg) Result, -,9 Satisfactory 7,6,7 Satisfactory, -,9 Satisfactory,7,56 Satisfactory, -, Satisfactory 6,9,7 Satisfactory Average, 9, -, Satisfactory,,9 Satisfactory SD,9 6, -, Satisfactory,,7 Satisfactory CV%, 9, -,7 Satisfactory,,7 Satisfactory Median,5 5, -,6 Satisfactory,,75 Satisfactory Minimum,, -,6 Satisfactory 5,56, Unsatisfactory Quartile 5,, -,56 Satisfactory 6 P Quartile 75,57, -,56 Satisfactory Maximum,56,5 -,7 Satisfactory Iqr,7, -, Satisfactory,9 -, Satisfactory 7,9 -, Satisfactory,9 -, Satisfactory, -, Satisfactory, -, Satisfactory,, Satisfactory 7,, Satisfactory 6,, Satisfactory,, Satisfactory,, Satisfactory,, Satisfactory 6,, Satisfactory,5, Satisfactory 9,6,7 Satisfactory
13 Cocaine conc. (ng/mg) Cocaine- Sample C Lab. Cocaine (ng/mg) Result Lab. Cocaine (ng/mg) Result 9, -, Satisfactory 6,5,6 Satisfactory 5, -,7 Satisfactory 7 6,5,6 Satisfactory, -,6 Satisfactory 6,6,6 Satisfactory Average 5,5 9,5 -,5 Satisfactory 6 6,7,6 Satisfactory SD,7 6,7 -,5 Satisfactory 9 6,,7 Satisfactory CV%,,7 -,9 Satisfactory 6,9,77 Satisfactory Median 5,, -,7 Satisfactory 5 6,96,7 Satisfactory Minimum,, -, Satisfactory 7,7,9 Satisfactory Quartile 5,55, -, Satisfactory 6,5,6 Satisfactory Quartile 75 6,65 6, -,6 Satisfactory,7, Satisfactory Maximum 9, 6, -, Satisfactory 9,5,6 Satisfactory Iqr,95, -, Satisfactory 9,,6 Satisfactory 5,6 -,6 Satisfactory 9,,6 Satisfactory,7 -, Satisfactory P,5 -, Satisfactory,5 -,7 Satisfactory,6 -,6 Satisfactory,6 -,5 Satisfactory,99 -, Satisfactory 5, Satisfactory 5 5,5,6 Satisfactory 7 5,6,6 Satisfactory 7 5,77, Satisfactory 5,9,6 Satisfactory 5 6,, Satisfactory 6,,5 Satisfactory
14 6 BE conc. (ng/mg) 6 BE- Sample C Lab. BE (ng/mg) Result Lab. BE (ng/mg) Result 5,69 -, Satisfactory 5,, Satisfactory 7, -,9 Satisfactory 7 9,6, Satisfactory,6 -,9 Satisfactory 5 9,5,5 Satisfactory Average 7,5 9,9 -, Satisfactory 9 9,76,57 Satisfactory SD, 9, -, Satisfactory,55,76 Satisfactory CV% 7,6 5, -,7 Satisfactory,5,9 Satisfactory Median 7,,5 -,69 Satisfactory,, Satisfactory Minimum,69,7 -,65 Satisfactory,, Satisfactory Quartile 5,9 6, -,6 Satisfactory,, Satisfactory Quartile 75 9,6,9 -,6 Satisfactory 6,, Satisfactory Maximum,7 5,7 -,9 Satisfactory,7,6 Satisfactory Iqr,6 6 6, -, Satisfactory >5 6,9 -, Satisfactory P 6, -,7 Satisfactory 6,6 -, Satisfactory 6,5 -, Satisfactory 7, -, Satisfactory 6 7, -, Satisfactory 7, Satisfactory 7,5, Satisfactory 7 7,9, Satisfactory 7,, Satisfactory 6 7,9, Satisfactory,, Satisfactory,, Satisfactory,, Satisfactory
15 Amphetamine conc. (ng/mg),5,,5,,5, Amphetamine- Sample C , Lab. Amphetamine (ng/mg) Result Lab. Amphetamine (ng/mg) Result 9,7 -, Satisfactory,5,5 Satisfactory,6 -, Satisfactory 5,,6 Satisfactory 6,9 -,75 Satisfactory 9, Questionable Average,6,95 -,69 Satisfactory SD,6, -,6 Satisfactory CV% 6,9, -,5 Satisfactory Median,5, -,5 Satisfactory Minimum,7, -,5 Satisfactory Quartile 5,, -,5 Satisfactory Quartile 75,9 7, -,5 Satisfactory Maximum,, -,5 Satisfactory Iqr,, -,5 Satisfactory 7, -,5 Satisfactory,5 Satisfactory The median Amphetamine concentration is below the,5 Satisfactory cut-off proposed by SoHT,6, Satisfactory (. ng/mg),6, Satisfactory 6,7,5 Satisfactory,7,5 Satisfactory 6,5,75 Satisfactory 5,9,5 Satisfactory,9,5 Satisfactory,9,5 Satisfactory,,6 Satisfactory,,7 Satisfactory 6,, Satisfactory
16 Methamphetamine conc. (ng/mg),5,5,,5,,5,,5,,5 Methamphetamine- Sample A Lab. Methamphet. (ng/mg) Result 9,5 -, Satisfactory,56 -,9 Satisfactory,6 -, Satisfactory Average, 9,7 -,67 Satisfactory SD,7 6,7 -,6 Satisfactory CV% 56,, -,5 Satisfactory Median,, -,5 Satisfactory Minimum,5 6, -,7 Satisfactory Quartile 5,9 7, -,7 Satisfactory Quartile 75,5, Satisfactory Maximum,, Satisfactory Iqr,6, Satisfactory, Satisfactory, Satisfactory The median Methamphetamine,,7 Satisfactory concentration is below the,,7 Satisfactory cut-off proposed by SoHT 5,, Satisfactory (. ng/mg),, Satisfactory 7,,5 Satisfactory,5,67 Satisfactory,5,67 Satisfactory 6,7 Satisfactory,,7 Satisfactory,9, Satisfactory 6,9, Satisfactory 5, 5, Unsatisfactory
17 ,5, MDMA- Sample C 5 MDMA conc. (ng/mg),5,, Lab. MDMA (ng/mg) Result Lab. MDMA (ng/mg) Result 6,6 -,7 Satisfactory 5,, Unsatisfactory,6 -,9 Satisfactory,7 -, Satisfactory Average,,7 -, Satisfactory SD,, -, Satisfactory CV%,97 9, -, Satisfactory Median,, -, Satisfactory Minimum,6, -,6 Satisfactory Quartile 5,,9 -,56 Satisfactory Quartile 75,,9 -,56 Satisfactory Maximum, 7,9 -,56 Satisfactory Iqr,6,9 -, Satisfactory,9 -, Satisfactory 6, Satisfactory The median MDMA concentration is below the, Satisfactory cut-off proposed by SoHT, Satisfactory (. ng/mg), Satisfactory 7, Satisfactory,, Satisfactory,, Satisfactory,, Satisfactory 9,,56 Satisfactory 6,,56 Satisfactory,5, Satisfactory 6,59,6 Satisfactory 5,6,9 Satisfactory
18 , 5,5 THC- Sample C 5, THC conc. (ng/mg),5,,5,, Lab. THC (ng/mg) Result 5, -,67 Satisfactory,6 -,7 Satisfactory 7,7 -, Satisfactory Average,,76 -,9 Satisfactory SD,7 6,77 -, Satisfactory CV% 5,5 9, -, Satisfactory Median,,9 -,6 Satisfactory Minimum,, -,5 Satisfactory Quartile 5,9, -,5 Satisfactory Quartile 75,5, -, Satisfactory Maximum, 6, -,7 Satisfactory Iqr,6, -,7 Satisfactory 7, Satisfactory, Satisfactory,,7 Satisfactory 5,,7 Satisfactory,,7 Satisfactory,5, Satisfactory 6,5, Satisfactory,56, Satisfactory,, Satisfactory 9,,7 Satisfactory,,5 Satisfactory 7,,5 Satisfactory 5,, Satisfactory 5,,7 Unsatisfactory
Drugs of Abuse I Serum
Drugs of Abuse I Serum 2017-11 1.10 For quality monitoring of quantitative measurements by chromatographic methods These reference materials are produced on the basis of human matrices. The highly accurate
More informationDOF. Scheme Description. Drugs in Oral Fluid Scheme
DOF Drugs in Oral Fluid Scheme Scheme Description LGC Standards Proficiency Testing 1 Chamberhall Business Park Chamberhall Green Bury Lancashire BL9 0AP United Kingdom Telephone: +44 (0) 161 762 2500
More information1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia
NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date
More informationValidation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens
Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens This document describes the validation of a Neogen Fentanyl kit for the semi-quantitative analysis of
More informationThe Drug Testing Process. Employer or Practice
Disclosures Clinical Professor, Jefferson Medical College BOD MROCC [Medical Review Officer Certification Council] BOD National Sleep Foundation BOD POEMS [Pennsylvania Occupational & Environmental Medicine
More informationSeptember HCMC Toxicology Transition: Additional information and Frequently Asked Questions
September 2016 HCMC Toxicology Transition: Additional information and Frequently Asked Questions Many clinicians have asked for more information about the Urine Drug Compliance Analysis (LAB8742) switch
More informationUrine drug testing it s not always crystal clear
Urine drug testing it s not always crystal clear Kirk Moberg, MD, PhD, FASAM Executive Medical Director, UnityPoint Health Illinois Institute for Addiction Recovery Clinical Professor of Internal Medicine
More informationUsing Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population
Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Adam S. Ptolemy 1, Colleen Murray 2, Edward Dunn 3,
More informationORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS
ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS Barry K Logan PhD, DABFT National Director of Forensic Services, NMS Labs Willow Grove PA Disclaimer
More informationEuropean Guidelines for Workplace Drug Testing in UrineandOral fluid
EWDTS European Workplace Drug Testing Society European Guidelines for Workplace Drug Testing in UrineandOral fluid 9th EWDTS Symposium in Lisbon Sanna Taskinen Michaela Neuhofer Updating project # 2 Current
More informationSchedule of Accreditation
Schedule of Accreditation Organisation Name Trading As INAB Reg No Contact Name Address Medical Bureau Of Road Safety 30T Helen Kearns Contact Phone No 01-7165555 Email Website Accreditation Standard Health
More informationDAU. Scheme Description. Drugs of Abuse in Urine Proficiency Testing Scheme
DAU Drugs of Abuse in Urine Proficiency Testing Scheme Scheme Description LGC Standards Proficiency Testing 1 Chamberhall Business Park Chamberhall Green Bury Lancashire BL9 0AP United Kingdom Telephone:
More informationLaboratory Testing to Support Pain Management: Methods, Concepts and Case Studies
Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Frederick G. Strathmann, PhD, DABCC, (CC,TC) Medical Director, Toxicology Associate Scientific Director of MS ARUP Laboratories
More information2012 DRUG RELATED DEATH STATISTICS JANUARY 1, 2012 THROUGH DECEMBER 31, 2012
JANUARY 1, 2012 THROUGH DECEMBER 31, 2012 All deaths counted in the column labeled ACCIDENTAL OVERDOSE were the direct result of the drugs ingested by the decedent. The drugs noted as being present came
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
Newmarket Road Fordham Ely Cambridgeshire CB7 5WW Contact: Rachel Hawkins Tel: +44 (0)1638 720500 Fax: +44 (0)1638 724200 E-Mail: rachel.hawkins@lgcgroup.com Website: www.lgcgroup.com Testing performed
More informationEvaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.
Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Logan FSF Emerging Forensic Scientist Award Oral Presentation Disclosure
More informationToxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey
Toxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey Kayla J. Lowrie, MS, Jennifer Turri, BS, Jill Yeakel, MSFS, Barry K. Logan, PhD, DABFT, Arcadia University, 450 S. Easton
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
Schedule of ccreditation United Kingdom ccreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK ccredited to Laboratory locations: Gavenny Court Brecon Road bergavenny Monmouthshire
More informationUrine Opioid Dependency Panel (UODP) 1
Drug Testing Panels Urine Opioid Dependency Panel (UODP) 1 Amphetamines Amphetamine Methamphetamine Methylenedioxyamphetamine Adderall, Dexedrine, Vyvanse, Lisdexamfetamine (Speed, Bennies, Crystal Meth,
More informationNeoSal Oral Fluid Collection System Solutions for Forensic Drug Detection
PERFORMANCE OF THE NEOSAL ORAL FLUID COLLECTION SYSTEM Neogen develops and manufactures a comprehensive range of ELISA test kits and accessories for forensic drug detection. Neogen offers solutions to
More informationDrug Testing Basics. by Erowid
Drug Testing Basics by Erowid INDEX 1. What do they Test for? 2. Test Types 3. Test Sensitivity 4. Detection Periods WHAT DO THEY TEST FOR? The first thing to know about drug testing is what the standard
More informationErnest D. Stewart, Chief Published Deputy January Coroner/Public 2018 Administrator
1 P a g e William F. Honsal, Sheriff Ernest D. Stewart, Chief Published Deputy January Coroner/Public 2018 Administrator METHODS Overview: The purpose of this report is to describe trends in the number
More informationPhysician s Reference for Urine and Blood Drug Testing and Interpretation
Physician s Reference for Urine and Blood Drug Testing and Interpretation DETECTIMED PANEL Urine (test code 70195) Screen Confirmation Screen Confirmation Alcohol Ethanol Amphetamines Amphetamine Methamphetamine
More informationLCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching
Liquid Chromatography Mass Spectrometry SSI-LCMS-8 LCMS-8 Drugs of Abuse: Analytes with Polarity Switching LCMS-8 Summary Seventy six analytes and their internal standards are described below. Multiple
More informationLaboratory Service Report
4 05/25/19 Client C702884-DLP ROCHESTER Amphetamines, Confirmation Positive Confirmed POSITIVE by LC-S/S for the following: Amphetamine = 52 ethamphetamine = 124 ethamphetamine exists in the d- and l-isomeric
More informationAlcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082
Alcohol The alcohol of interest is ethanol. Ethanol has a sedative effect in the brain. Ethanol intoxication symptoms include blurred vision, slurred speech, poor coordination and difficulty thinking depending
More informationDRUG & ALCOHOL TESTING YOUR QUESTIONS ANSWERED
DRUG & ALCOHOL TESTING YOUR QUESTIONS ANSWERED Need some advice on testing? Call us free on: 0800 036 2522 Cellmark s Hair Testing Service Cellmark s ISO17025 accredited hair drug & alcohol testing service
More informationEuropean Guidelines for Workplace Drug Testing in Blood and Blood Spots
EWDTS European Workplace Drug Testing Society European Guidelines for Workplace Drug Testing in Blood and Blood Spots 9th EWDTS Symposium in Lisbon Wim Schielen 29-5-2015, Lisbon Updating project # 2 Current
More informationDetection of Drugs-of-Abuse by Tandem Mass Spectrometry.
Detection of Drugs-of-Abuse by Tandem Mass Spectrometry. Dr Tim Laurens MSc.Chem(Pretoria), Ph.D. Chem (Pretoria), MSc.Toxicology (Surrey,UK) FRSChem, MFSSoc Email: laurensj@lancet.co.za / tim.laurens@up.ac.za
More informationQuest Diagnostics Drug Testing Index Full Year 2015 Tables
Quest Diagnostics Drug Testing Index Full Year 2015 Tables Table 1. Annual Positivity Rates Urine Drug Tests (For Combined U.S. Workforce) (More than 9.5 million tests from January to December 2015) Year
More informationTesting for Controlled Substances
Testing for illicit drugs Testing for Controlled Substances 1 Purposes: Employment Sports Screening medical eval. Legal Monitoring Treatment Probation Prescribing controlled substances Forensics 2 Drug
More informationApplications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD.
Applications of High Resolution Mass Spectrometry in Forensic Toxicology Patrick Kyle, PhD pkyle@umc.edu Financial Disclosures Grant/Research Support: None Salary/Consultant Fees: None Board/Committee/Advisory
More informationLABORATORY TECHNICAL SPECIFICATIONS MANUAL
LABORATORY TECHNICAL SPECIFICATIONS MANUAL Produced by Controlled Document ID 103.0025 November 2017 Version 17 Ltd Gavenny Court, Brecon Road, Abergavenny, Monmouthshire NP7 7RX, United Kingdom Limited
More informationLABORATORY TECHNICAL SPECIFICATIONS MANUAL
LABORATORY TECHNICAL SPECIFICATIONS MANUAL Produced by Synergy Health Laboratory Services Controlled Document ID 103.00250 January 2015 - Version 9 Purpose of Procedure This document outlines the technical
More informationLABORATORY TECHNICAL SPECIFICATIONS MANUAL
LABORATORY TECHNICAL SPECIFICATIONS MANUAL Produced by Synergy Health Laboratory Services Controlled Document ID 103.00250 August 2015 - Version 12 Purpose of Procedure This document outlines the technical
More informationFrequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up
Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Dr. Bhushan M. Kapur Associate Professor Department of Laboratory Medicine and Pathobiology, Faculty
More informationDoes ultram show up as an opiate
Search Does ultram show up as an opiate Tramadol ( Ultram ) is prescribed for treating moderate to severe pain in adults. 19-2-2018 I took Tramadol Hydrochloride for 6 months due to joint pain from my
More informationUrine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016
Urine Drug Testing Methadone/Buprenorphine 101 Workshop Ron Joe, MD, DABAM December 10, 2016 Learning objectives Clarify the purpose of urine drug testing (UDT) Distinguish between UDT for detection of
More informationAgilent Clinical LC/MS: Review of Established LC-MS QQQ Clinical Research Applications. dr. Jan Srbek, HPST. Page 1
Agilent Clinical LC/MS: Review of Established LC-MS QQQ Clinical Research Applications dr. Jan Srbek, HPST Page 1 Major LC-MS Clinical Applications Steroids/Endocrinology Vitamin D Testosterone, Estradiol
More informationINTERPATH LABORATORY, INC. TEST UPDATES
EFFECTIVE DATE: February 16, 2016 INTERPATH LABORATORY, INC. TEST UPDATES Please take note of the following test updates and make the appropriate changes in your Interpath Service Manual. Feel free to
More informationTest Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine
Reporting Title: Pain Clinic Drug Screen, CoC, U Performing Location: Rochester Specimen Requirements: Container/Tube: Chain-of-Custody Kit (Supply T282) containing the specimen containers, seals, and
More informationNational Drug-Related Deaths Index
HRB Bulletin Drug Deaths 2015 National Drug-Related Deaths Index 2004 to 2015 data Overview This update presents figures from the National Drug- Related Deaths Index (NDRDI) on deaths due to poisoning
More informationEuropean Guidelines for Workplace Drug and Alcohol Testing in Hair
Foreword These guidelines for Legally Defensible Workplace Drug Testing have been prepared and updated by the European Workplace Drug Testing Society (EWDTS). They are based on the 2010 version published
More informationCozart DDS Drug Detection System On-site Saliva Drug Testing
Cozart DDS Drug Detection System On-site Saliva Drug Testing www.siemens.com Siemens Healthcare Diagnostics Drug Testing, under the Cozart brand name, has more than a 10-year legacy of providing an extensive
More informationUrine Drug Testing Methods 3-5
Urine Drug Testing Methods 3-5 Type of Test Logistics Pearls Initial Screening Test: Immunoassay Confirmatory Test: Gas chromatography-mass spectrometry (GCMS) + or Liquid chromatography-mass spectrometry
More informationOxymorphone Distribution in Biological Matrices: A Collection of Case Studies
Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies Brian Simons, Forensic Toxicologist Montgomery County Coroner s Office / Miami Valley Regional Crime Laboratory May 1, 2008
More informationDrug Profiles of Apprehended Drivers in Victoria
Drug Profiles of Apprehended Drivers in Victoria J Gerostamoulos, P McCaffrey, O H. Drummer and M Odell*. Victorian Institute of Forensic Medicine, Department of Forensic Medicine, Monash University, 57-83
More informationA Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS
A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS Introduction Drug analysis from whole blood is gaining popularity due to a more complete measurement
More informationFully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids
PO-CON1753E Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids ASMS 2017 TP-442 Joshua F. Emory 1, Nathan DeFreitas 2, Michael Roberts 1, Manoj Tyagi 2, M.
More informationThe Utility of Urine Drug Screening
The Utility of Urine Drug Screening Treating Addiction, Saving Lives Sea Cruises Bye Tazmania, still far from New Zealand February 8 th, 2018 Mandy Manak, MD FASAM, ISAM, CSAM, MRO Medical Director, ICDO
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationControlled Substance Monitoring in the Age of the Opioid Epidemic
Controlled Substance Monitoring in the Age of the Opioid Epidemic Paul E. Hilliard, MS, MD Hospital Pain Committee Chair Department of Anesthesiology CME housekeeping I have no financial disclosures AKA,
More informationbiasing factor in hair analysis
Forensic Science International 107 (2000) 13 38 www.elsevier.com/ locate/ forsciint Statistical examination of hair as a potential q biasing factor in hair analysis Tom Mieczkowski Ph.D. *, Richard Newel
More informationContract No. 952-M1 Collection Service Requirements Texas Department of Criminal Justice (TDCJ)
The services and requirements referenced are specific to Texas Department of Criminal Justice (TDCJ) and are in addition to and may include the services and must be in compliance with the requirements
More informationDriving Under The Influence Of Drugs In Ireland: A Growing And Significant Danger
Driving Under The Influence Of Drugs In Ireland: A Growing And Significant Danger D.A.Cusack, G.Harrington, P.Furney, K.Flynn and C.P.Leavy Medical Bureau of Road Safety, Department of Forensic Medicine,
More informationWELCOME! 12/13/2018. Today s Topic: Urine Drug Screens in OUD Treatment UW PACC
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences 12/13/2018 WELCOME! Today s Topic: Urine Drug Screens in OUD Treatment Should I test and how should I do drug testing
More informationDeposition Characteristics of Methamphetamine and Amphetamine in Fingernail Clippings and Hair Sections
Deposition Characteristics of Methamphetamine and Amphetamine in Fingernail Clippings and Hair Sections Dong-Liang Lin 1, Rea-Ming Yin 1, Hsiu-Chuan Liu 1, Chung-Yi Wang 1, and Ray H. Liu 2,3, * 1 Institute
More information3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years
Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - MEDICATION DETECTED (PARENT DRUG
More informationINSTANT DRUG SCREENING
................................ INSTANT DRUG SCREENING Rapid tests for the detection of drugs and their metabolites in urine and saliva A CEuropean Background NHS Supply Chain Approved Reliable, quick
More informationTest Definition: PCDSO Pain Clinic Drug Screen, Urine
Reporting Title: Pain Clinic Drug Screen, U Performing Location: Rochester Specimen Requirements: Collection Container/Tube: Plastic urine container Submission Container/Tube: Plastic, 60-mL urine bottle
More informationDrug Overdose Summary- Mendocino County, CA. Mendocino County Health & Human Services Agency Healthy People, Healthy Communities
Drug Overdose Summary- Mendocino County, CA Mendocino County Health & Human Services Agency Healthy People, Healthy Communities Injury Fact Sheet: Mendocino County Drug Overdose Summary Tables Deaths 2002
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationLyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.
Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory Lyndsey.Knoy@wsp.wa.gov Forensic Toxicology is an interdisciplinary science that analyzes blood, fluid and/or tissues for
More informationLinking Opioid Treatment in Primary Care. Roxanne Lewin M.D.
Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals
More informationONLINE DAT II Results matter.
From tough questions to reliable answers. ONLINE DAT II Results matter. Patient results matter Reputations are at stake: theirs and yours. Behind every Drugs-of-Abuse Test (DAT) result is a person whose
More informationA Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography
Application Note LCMS-109 A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography Time of Flight (LC-TOF) Mass Spectrometry Introduction Many clinical
More informationDr Alistair Dunn. Lead Clinician Northland Health Community Mental Health & Addictions Northland DHB Whangarei
Dr Alistair Dunn Lead Clinician Northland Health Community Mental Health & Addictions Northland DHB Whangarei 8:30-9:25 WS #147: The Bottom Line; Tackling the Problem of Prescribed Drug Addiction 9:35-10:30
More informationInterpretation of Workplace Tests for Cannabinoids
J. Med. Toxicol. (2017) 13:106 110 DOI 10.1007/s13181-016-0587-z PROCEEDINGS Interpretation of Workplace Tests for Cannabinoids Ken Kulig 1 Received: 17 May 2016 /Revised: 16 August 2016 /Accepted: 6 September
More informationPain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX
Pain Management and Compliance Toxicology Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Prescription Drug Abuse: A National Problem Prescription drug abuse is a growing
More informationUrine Drug Testing to Monitor Opioid Use In Managing Chronic Pain
Faculty Disclosure Henry C. Nipper, PhD, DABCC Dr. Nipper has listed no financial interest/arrangement that would be considered a conflict of interest. Urine Drug Testing to Monitor Opioid Use In Managing
More informationClearing Up The Confusion About Substance Abuse Testing
Clearing Up The Confusion About Substance Abuse Testing 2018 Indiana Safety and Health Conference and Expo Presented by Tiffany Ellefson, DISA/Midwest Toxicology Services Items to cover Latest Trends in
More informationForensic Toxicology Scope of Testing and Detection Limits
Forensic Toxicology Scope of Testing and Detection Limits Table of Contents QUALITATIVE ANALYSES... 2 Volatile Screen by GC/FID... 2 Carbon Monoxide by Microdiffusion... 2 Ethylene Glycol by GC/MS... 2
More informationChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016)
ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016) Email: DREtox@chematox.com; Phone: (303)440-4500 Always identify any medications/drugs the suspect states they have taken, or that you suspect
More informationSubstance Abuse Testing Electronic Result Reporting Layout Specifications. Version 3.2 January 2004
Substance Abuse Testing Electronic Result Reporting Layout Specifications Version 3.2 January 2004 Copyright Notice This publication is produced and distributed by LabOne, Inc. to specify the content and
More informationDrugSmartCup & DrugSmartDip Accuracy Report as produced by Ameditech, Inc.
Accuracy The accuracy of the DrugSmart Drugs of Abuse Tests was evaluated in comparison to commercially available drug screen tests. Sixty (60) negative urine samples collected from presumed non-user volunteers
More informationRapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab
Application Note Clinical Research Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab Authors Adam Barker 1,2, Frederick G. Strathmann 3, Natalie N. Rasmussen 4, and Carrie
More informationRapid screen of Urine Samples for amphetamines, cocaine, methamphetamine, opiates (heroin), marijuana and MDMA (ecstasy)
Self Screen Book WH_290119_99x180 29/01/2019 12:41 Page 1 Home DrugTest Rapid screen of Urine Samples for amphetamines, cocaine, methamphetamine, opiates (heroin), marijuana and MDMA (ecstasy) Instructions
More informationCross-reactivity reactivity in EMIT
Blood Drug Analysis at the State Bureau of Investigation Crime Laboratory Richard W. Waggoner, Jr. Sample Requirements 2-10 ml gray top vacutainers At least 10 ml of urine sample for drug facilitated sexual
More informationCutoff levels for hydrocodone in a blood test
Cutoff levels for hydrocodone in a blood test The premier DNA and drug testing company in the North Texas area. Specializing in legal cases but also provide testing for employers and private individuals.
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationGet Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization
Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization Prepared and presented by Jennifer Bolen, JD Disclosures for Jennifer Bolen, JD Consultant - Generation
More information3/8/2018. Reasons for Doing UDT. UDT: A Tool in Risk Assessment. Faculty/Presenter Disclosure. Urine Drug Testing in Chronic Pain Management
Urine Drug Testing in Chronic Pain Management March 8, 2018 Faculty/Presenter Disclosure Faculty: Andrew J Smith, MDCM Relationships with commercial interests: None to report Andrew J Smith, MDCM Staff
More information10/9/18. Learning Objectives. Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization
Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization Prepared and presented by Jennifer Bolen, JD Disclosures for Jennifer Bolen, JD Consultant - Generation
More informationHSE National Drug Treatment Centre Drug Analysis Laboratory. A Guide to Service Users
HSE National Drug Treatment Centre Drug Analysis Laboratory A Guide to Service Users 5 th Edition May 2015 Contents Page Introduction iii General Information iv Samples for Drug Analysis 1 Consent 1 Packaging
More informationLC Application Note. Dangerous driver?
LC Application Note Dangerous driver? www.palsystem.com Dangerous driver? Robert M. Sears 1 ; Kenneth C. Lewis 2 ; and Kim Gamble 3 1 SC Law Enforcement Division, Columbia, SC 29221; 2 OpAns LLC, Durham
More informationDane County Oral Fluid Pilot Project- Establishing an Oral Fluid Drug Testing Program in Alabama
Dane County Oral Fluid Pilot Project- Establishing an Oral Fluid Drug Testing Program in Alabama Curt Harper, Ph.D., F-ABFT Alabama Department of Forensic Sciences Candace Lightner, Founder and President
More informationOverview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients
Overview of the AACC Academy s LMPG: Using clinical laboratory tests to monitor drug therapy in pain management patients Gwen McMillin, PhD, DABCC(CC,TC) Professor, University of Utah Medical Director,
More informationPatient-Centered Urine Drug Testing. Douglas Gourlay, MD, MSc, FRCPC, FASAM
Patient-Centered Urine Drug Testing Douglas Gourlay, MD, MSc, FRCPC, FASAM Declaration of Potential Conflict of Interest The content of this presentation is non- commercial and does not represent any conflict
More informationNARCOTIC NOTES FLIPBOOK BY: PER:
NARCOTIC NOTES FLIPBOOK BY: PER: 1 https://www.youtube. com/watch?v=lolb21bii-a 2 Laws, Collection, & Preservation Narcotic Drugs = natural or synthetic substance that produces bodily (physiological) or
More information[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS
A Comprehensive Method for the Analysis of Pain Management Drugs and Drugs of Abuse Incorporating Simplified, Rapid Mixed-Mode SPE with UPLC-MS/MS for Clinical Research Jonathan P. Danaceau, Scott Freeto,
More informationThe influence of the sample matrix on LC-MS/MS method development and analytical performance Koster, Remco
University of Groningen The influence of the sample matrix on LC-MS/MS method development and analytical performance Koster, Remco IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationWelcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017
Welcome! Supreme Court of Ohio Specialized Dockets Conference October 23-24, 2017 Drug Testing: Do you know enough to be dangerous? Presented by William L. Parker President & CEO American Court & Drug
More informationDrug & Alcohol Testing
Drug & Alcohol Testing Health & Wellbeing in your workplace 1300 453 688 ClinicalLabs.com.au Drug & Alcohol Testing Drug and alcohol misuse is estimated to cost Australian businesses billions of dollars
More informationNIAID DAIDS FLOW CYTOMETRY LABORATORY CERTIFICATION
January 21, 2010 NIAID DAIDS FLOW CYTOMETRY LABORATORY CERTIFICATION Laboratories performing flow cytometric enumeration of lymphocyte subsets for NIAIDsponsored studies must participate in the NIAID DAIDS
More informationWhat Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital
What Your Drug Test Really Means Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital Disclosure There are no relevant financial relationships with commercial interests associated.
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationPain Medication Management Program Monitors Patient Compliance
PeaceHealth Laboratories UPDATE 2014/15 Edition Pain Medication Management Program Monitors Patient Compliance BENEFITS Monitors analgesic medication adherence to ensure patient safety and protect your
More informationPain Medication Management Program Supports Patient Outcomes and Adherence
PeaceHealth Laboratories UPDATE 2015 Revised Edition Pain Medication Management Program Supports Patient Outcomes and Adherence BENEFITS Monitors analgesic medication adherence to ensure patient safety
More informationValidation of an Automated Method to Remove
Shahana Wahab Huq 1, Richard Thomas 2, Agnes Cua 2, Seyed Sadjadi 1 1 Phenomenex, 411 Madrid Avenue, Torrance, CA 951 2 Precision Toxicology, 33 Bunker Hill Street, San Diego, CA 9219 Validation of an
More information